Hepatitis C Testing Algorithm
Begin screening with an HCV antibody test, and if reactive, automatically perform HCV RNA testing on the same blood sample to confirm current infection—this two-step sequence is essential for diagnosis. 1
Initial Screening Test
Start with an HCV antibody test using either:
- Laboratory-based immunoassay (preferred for reflex testing capability)
- FDA-approved rapid test (OraQuick HCV Rapid Antibody Test)
A reactive antibody result indicates one of three possibilities: current infection, past resolved infection, or false positivity 2. Do not stop at antibody testing alone—approximately one-third of patients historically have incomplete testing when HCV RNA is not performed 3.
Confirmatory Testing
For Reactive Antibody Results:
Immediately perform HCV RNA testing (nucleic acid test/NAT) to distinguish between:
- HCV RNA detected = Current active infection requiring treatment
- HCV RNA not detected = Past resolved infection or false-positive antibody 1, 2
Critical Implementation Strategy:
Use single-visit sample collection with automatic reflex testing. When the antibody test is reactive, the laboratory should automatically run HCV RNA on the same blood specimen without requiring a second visit or provider order 3. This approach eliminates incomplete testing and is now the standard of care.
Special Testing Scenarios
Recent Exposure (Within 6 Months):
- Test directly for HCV RNA OR
- Perform follow-up HCV antibody testing (antibodies may not yet be detectable in acute infection) 1
Immunocompromised Patients:
Recurrent HCV Infection:
- Begin with HCV RNA testing rather than antibody 1
Additional Testing After Diagnosis
Once current HCV infection is confirmed (HCV RNA positive):
- Quantitative HCV RNA level
- HCV genotype determination (though pan-genotypic regimens have reduced the clinical urgency of this)
- Fibrosis assessment using FIB-4 score or other non-invasive methods 1
Common Pitfalls to Avoid
- Never rely on antibody testing alone—this is the most common error leading to missed diagnoses of active infection
- Discontinue strategies requiring multiple visits for sample collection 3
- Do not assume negative antibody means no infection in recently exposed or immunocompromised patients
- Ensure laboratory reporting systems are configured for automatic reflex RNA testing on reactive antibody samples
Alternative Testing Method
HCV core antigen testing is an emerging alternative to RNA testing with 93.4% sensitivity and 98.8% specificity (Abbott ARCHITECT assay), particularly useful in resource-limited settings 4. However, RNA testing remains the gold standard in most clinical settings.